Eric M. Ostertag

Chief Executive Officer & Founder at Poseida Therapeutics, Inc.

Eric M. Ostertag

Eric M. Ostertag

Chief Executive Officer & Founder at Poseida Therapeutics, Inc.

Biography

Founder of Poseida Therapeutics, Inc., PhenoTech, Inc., Transposagen Biopharmaceuticals, Inc. and Vindico NanoBioTechnology LLC, Eric M. Ostertag presently holds the position of Chief Executive Officer & Director at Poseida Therapeutics, Inc. Dr. Ostertag is also on the board of Hera Testing Laboratories, Inc. In his past career he held the position of President & Chief Executive Officer for Transposagen Biopharmaceuticals, Inc., Vice President-Research at PhenoTech, Inc. and President & Chief Executive Officer at Vindico NanoBioTechnology LLC. Eric M. Ostertag received an undergraduate degree from the University of Wisconsin and a doctorate from the University of Pennsylvania.

Overview
Career Highlights

Poseida Therapeutics, Inc.
Transposagen Biopharmaceuticals, Inc.

RelSci Relationships

756

Number of Boards

2

Birthday

1973

Age

48

Relationships
RelSci Relationships are individuals Eric M. Ostertag likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Business Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at AFYX Therapeutics AS

Relationship likelihood: Strong

Executive Partner, Private Equity at Sofinnova Investments, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

General Counsel, Chief Compliance Officer & Corporate Secretary at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Longitude Capital Management Co. LLC

Relationship likelihood: Strong

Chief Human Resources Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chair at The Executive Leadership Foundation

Relationship likelihood: Strong

Partner at Brandon Point Industries Ltd.

Relationship likelihood: Strong

Paths to Eric M. Ostertag
Potential Connections via
Relationship Science
You
Eric M. Ostertag
Chief Executive Officer & Founder at Poseida Therapeutics, Inc.
Education
MD & Ph.D. Medicine & Molecular Biology
Class of 2002

The University of Pennsylvania is the oldest and one of the finest medical schools in the United States. Penn is rich in tradition and heritage and at the same time consistently at the forefront of new developments and innovations in medical education and research. Since its founding in 1765 the School has been a strong presence in the community and prides itself on educating the leaders of tomorrow in patient care, biomedical research, and medical education. At Penn academic excellence, as well as compassion for the patients we are privileged to serve, are stressed. Skillful compassion is truly a hallmark of the Penn learning experience. The Perelman School of Medicine at the University of Pennsylvania consistently ranks among the top five in US News and World Report’s rankings of research-oriented medical schools.

B.S. Genetics
Class of 1995

The University of Wisconsin–Madison has long been recognized as one of America's great universities. A public, land-grant institution, UW–Madison offers a complete spectrum of liberal arts studies, professional programs and student activities. Spanning 936 acres along the southern shore of Lake Mendota, the campus is located in the city of Madison.

Class of 2002

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Career History
Vice President-Research
2003 - 2007

PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA.

Founder & Chief Executive Officer
2003 - 2005

Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY.

Chief Executive Officer & Founder
2014 - Current

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Boards & Committees
Chief Executive Officer & Chairman of the Board
2014 - Current

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Director
Tenure Unconfirmed

Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY.

Transactions
Details Hidden

Poseida Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Poseida Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Poseida Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Details Hidden

PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA.

Details Hidden

Transposagen Biopharmaceuticals, Inc. operates as a biotechnology company. Its products and services include piggyBac Reagents, cell engineering services and gene editing reagents & kits. The company was founded by Ostertag M. Eric in 2005 and is headquartered in Lexington, KY.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Eric M. Ostertag. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Eric M. Ostertag's profile does not indicate a business or promotional relationship of any kind between RelSci and Eric M. Ostertag.